Cronos Group (NASDAQ:CRON – Get Free Report) will release its earnings data before the market opens on Thursday, May 9th. Analysts expect Cronos Group to post earnings of ($0.01) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.
Cronos Group (NASDAQ:CRON – Get Free Report) last posted its quarterly earnings data on Thursday, February 29th. The company reported ($0.05) earnings per share (EPS) for the quarter. Cronos Group had a negative net margin of 84.15% and a negative return on equity of 3.99%. The firm had revenue of $23.92 million during the quarter, compared to analysts’ expectations of $25.15 million. On average, analysts expect Cronos Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Cronos Group Price Performance
Shares of NASDAQ CRON opened at $2.71 on Thursday. The stock’s 50-day moving average is $2.39 and its two-hundred day moving average is $2.14. Cronos Group has a 1-year low of $1.64 and a 1-year high of $2.99. The company has a market cap of $1.04 billion, a price-to-earnings ratio of -14.26 and a beta of 1.17.
Analyst Upgrades and Downgrades
View Our Latest Analysis on Cronos Group
Cronos Group Company Profile
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
See Also
- Five stocks we like better than Cronos Group
- Which Wall Street Analysts are the Most Accurate?
- AMD is Down 35%. Now is the Time to Buy the Dip
- What Do S&P 500 Stocks Tell Investors About the Market?
- Amazon Stands Tall: New Highs Are in Sight
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.